Cargando…
Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer
Ornithine decarboxylase (ODC) is the rate-limiting enzyme of polyamine synthesis. The two ODC antizyme inhibitors (AZIN1) and (AZIN2) are regulators of the catalytic activity of ODC. While AZIN1 is a regulator of cell proliferation, AZIN2 is involved in intracellular vesicle transport and secretion....
Autores principales: | Kaprio, Tuomas, Rasila, Tiina, Hagström, Jaana, Mustonen, Harri, Lankila, Petri, Haglund, Caj, Andersson, Leif C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377119/ https://www.ncbi.nlm.nih.gov/pubmed/30768610 http://dx.doi.org/10.1371/journal.pone.0211564 |
Ejemplares similares
-
Expression of ODC Antizyme Inhibitor 2 (AZIN2) in Human Secretory Cells and Tissues
por: Rasila, Tiina, et al.
Publicado: (2016) -
REG4 Independently Predicts Better Prognosis in Non-Mucinous Colorectal Cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014) -
Determinants of the Differential Antizyme-Binding Affinity of Ornithine Decarboxylase
por: Liu, Yen-Chin, et al.
Publicado: (2011) -
Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme
por: Matsufuji, Senya, et al.
Publicado: (1995) -
Structural and degradative aspects of ornithine decarboxylase antizyme inhibitor 2
por: Ramos-Molina, Bruno, et al.
Publicado: (2014)